Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data
JMIR Public Health and Surveillance · 2024
DOI: 10.2196/51054 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Public Health and Surveillance, 2024. Verfasst von Lindsay Shea und 9 weiteren Autor:innen. Beteiligte Einrichtung: AJ Drexel Autism Institute, Drexel University, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Autistic Disorder, COVID-19 Vaccines, Immunization, Secondary, Patient Acceptance of Health Care. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The autistic population is rapidly increasing; meanwhile, autistic adults face disproportionate risks for adverse COVID-19 outcomes. Limited research indicates that autistic individuals have been accepting of initial vaccination, but research has yet to document this population’s perceptions and acceptance of COVID-19 boosters.
Objective
This study aims to identify person-level and community characteristics associated with COVID-19 vaccination and booster acceptance among autistic adults, along with self-reported reasons for their stated preferences. Understanding this information is crucial in supporting this vulnerable population given evolving booster guidelines and the ending of the public health emergency for the COVID-19 pandemic.
Methods
Data are from a survey conducted in Pennsylvania from April 11 to September 12, 2022. Demographic characteristics, COVID-19 experiences, and COVID-19 vaccine decisions were compared across vaccination status groups. Chi-square analyses and 1-way ANOVA were conducted to test for significant differences. Vaccination reasons were ranked by frequency; co-occurrence was identified using phi coefficient correlation plots.
Results
Most autistic adults (193/266, 72.6%) intended to receive or received the vaccine and booster, 15% (40/266) did not receive or intend to receive any vaccine, and 12.4% (33/266) received or intended to receive the initial dose but were hesitant to accept booster doses. Reasons for vaccine acceptance or hesitancy varied by demographic factors and COVID-19 experiences. The most significant were previously contracting COVID-19, desire to access information about COVID-19, and discomfort with others not wearing a mask (all P=.001). County-level factors, including population density (P=.02) and percentage of the county that voted for President Biden (P=.001) were also significantly associated with differing vaccination acceptance levels. Reasons for accepting the initial COVID-19 vaccine differed among those who were or were not hesitant to accept a booster. Those who accepted a booster were more likely to endorse protecting others and trusting the vaccine as the basis for their acceptance, whereas those who were hesitant about the booster indicated that their initial vaccine acceptance came from encouragement from someone they trusted. Among the minority of those hesitant to any vaccination, believing that the vaccine was unsafe and would make them feel unwell were the most often reported reasons.
Conclusions
Intention to receive or receiving the COVID-19 vaccination and booster was higher among autistic adults than the population that received vaccines in Pennsylvania. Autistic individuals who accepted vaccines prioritized protecting others, while autistic individuals who were vaccine hesitant had safety concerns about vaccines. These findings inform public health opportunities and strategies to further increase vaccination and booster rates among generally accepting autistic adults, to better support the already strained autism services and support system landscape. Vaccination uptake could be improved by leveraging passive information diffusion to combat vaccination misinformation among those not actively seeking COVID-19 information to better alleviate safety concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AJ Drexel Autism Institute, Drexel University, Philadelphia, PA, United States.
- College of Public Health, Temple University, Philadelphia, PA, United States.
- Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States.
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
- College of Health and Human Development, Pennsylvania State University, University Park, PA, United States.
ORCID-Profile: Lindsay Shea, Dylan Cooper, Jonas Ventimiglia, Shelby Frisbie, Conner Carlton, Wei Song, Mark Salzer, Brian Lee, Emily Hotez, David J Vanness
Zitieren
APA
Shea, L., Cooper, D., Ventimiglia, J., Frisbie, S., Carlton, C., Song, W., Salzer, M., Lee, B., Hotez, E., & Vanness, D. J. (2024). Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data. JMIR Public Health and Surveillance. https://doi.org/10.2196/51054
Vancouver
Shea L, Cooper D, Ventimiglia J, Frisbie S, Carlton C, Song W, et al. Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data. JMIR Public Health and Surveillance. 2024. doi:10.2196/51054
BibTeX
@article{Shea2024,
author = {Shea, Lindsay and Cooper, Dylan and Ventimiglia, Jonas and Frisbie, Shelby and Carlton, Conner and Song, Wei and Salzer, Mark and Lee, Brian and Hotez, Emily and Vanness, David J},
title = {Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data},
journal = {JMIR Public Health and Surveillance},
year = {2024},
doi = {10.2196/51054}
}
EUVIMED